Skip to content

Ultrasound-guided ALSP for postoperative analgesia in patients undergoing total hip arthroplasty: a randomized controlled trial

Ultrasound-guided ALSP for postoperative analgesia in patients undergoing total hip arthroplasty: a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078323
Enrollment
Unknown
Registered
2023-12-05
Start date
2023-12-06
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoarthritis of the hip, osteonecrosis of the femoral head (Ficat IIIB or IV), and developmental dysplasia of the hip

Interventions

Sponsors

Department of Anesthesiology, West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients who require unilateral initial THA surgery due to hip osteoarthritis, joint destruction, aseptic necrosis of the femoral head, femoral neck fracture, etc; (2) Age range from 18 to 80 years old, regardless of gender; (3) Body mass index is 20-35 kg/m2; (4) The preoperative American Society of Anesthesiologists (ASA) anesthesia risk assessment is graded as Grade I-III; (5) Patients who have signed informed consent forms.

Exclusion criteria

Exclusion criteria: (1) Long term use of opioid drugs (daily or almost daily use of opioid drugs for more than 3 months); (2) Alcohol or drug abuse or allergic reactions to any drugs (local anesthetics, etc.) used in this study; (3) Patients with mental illness, language disorders, and inability to complete the Visual Analog Scale (VAS) for pain assessment; (4) Patients with peripheral neuropathy on the surgical side may have moderate to severe joint deformities or stiffness on the surgical side; (5) Individuals with a history of hip trauma or asymmetrical sensation in both hips; (6) Local skin infection, bleeding, etc. at the site of anesthesia puncture; (7) Abnormal coagulation function (PT, APTT exceeding normal values, INR<=1.4), platelet count<80 × 109/L), Patients with possible abnormal platelet function; (8) Surgeons or anesthesiologists believe that patients are not suitable for inclusion; (9) Patients with surgery time greater than 90 minutes.

Design outcomes

Secondary

MeasureTime frame
Dosage of morphine within 24 h after surgery;Dosage of morphine within 24 h after surgery;Postoperative Visual Analogue Scale Score at rest;Postoperative Visual Analogue Scale Score at motion;Times of sleep interruption due to pain on the night of surgery;Postoperative quadriceps strength;Time until the first walkout of bed after surgery;Time to hospital discharge;postoperative adverse events;

Primary

MeasureTime frame
quality of recovery-15 score;

Countries

China

Contacts

Public ContactYang Jing

West China Hospital, Sichuan University

yangjing@wchscu.cn+86 189 8060 2269

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026